Chester County News and Community Website
RADNOR, PA — Pennsylvania-based biopharmaceutical company NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced a significant development in its ongoing clinical trial for a novel treatment for bipolar depression. The company …
NRx Pharmaceuticals Completes Enrollment for Bipolar Depression Trial, Eyes Q2 Readout Read More
SPRING HOUSE, PA — Johnson & Johnson recently announced that its investigational drug, nipocalimab, has received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA). The designation …
FDA Grants Breakthrough Therapy Status to Johnson & Johnson’s Nipocalimab for HDFN Treatment Read More SPRING HOUSE, PA — In a remarkable breakthrough for the healthcare industry, Johnson & Johnson’s investigational targeted oral peptide, JNJ-2113, has displayed positive results in a Phase 2b study for …
Promising Breakthrough in Psoriasis Treatment: Johnson & Johnson’s JNJ-2113 Achieves Stellar Results Read More
KING OF PRUSSIA, PA — Global biotech leaders CSL and Arcturus Therapeutics have released the results of a six-month follow-up analysis comparing their self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine, ARCT-154, …
CSL’s ARCT-154 Vaccine Outperforms Comirnaty in Six-Month COVID-19 Study Read More SPRING HOUSE, PA — Johnson & Johnson has recently revealed encouraging results from trials of nipocalimab, a new drug that could offer hope to adults suffering from generalized myasthenia gravis …
Johnson & Johnson’s Nipocalimab Shows Promise in Treating Rare Autoantibody Diseases Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals (NASDAQ: MDGL) recently took a significant stride towards introducing the first treatment for Nonalcoholic Steatohepatitis (NASH) with liver fibrosis. The drug, resmetirom, has cleared a …
Breakthrough in Liver Disease Treatments: Madrigal’s Resmetirom Aims to Be the First Approved NASH Therapy Read More
GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a pioneering international research initiative, committing over $500,000 to two multiyear projects aimed at developing treatments for the most prevalent demyelinating …
New Research Initiative Targets Common Forms of Charcot-Marie-Tooth Disease Read More
MALVERN, PA — YPrime, a leading provider of electronic clinical outcomes assessment (eCOA) platforms, has released the results of a comprehensive survey examining the experiences and perspectives of clinical stakeholders …
YPrime Unveils Key Insights into eCOA Adoption and Concerns in Clinical Research Read More
WEST CHESTER, PA — VESTECK, Inc.’s revolutionary “SUTURE-TIGHT”™ catheter technology was spotlighted at the prestigious International Symposium on Endovascular Therapy (ISET) meeting held in Miami, FL, on January 24, 2024.
VESTECK’s “SUTURE-TIGHT” Catheter Technology Takes Center Stage at ISET Meeting Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a Pennsylvania-based biopharmaceutical company, recently announced it has completed enrollment for its Phase 2b/3 study of NRX-101. This patented combination of D-cycloserine, …
NRx Pharmaceuticals Completes Enrollment in Pivotal Trial for Suicidal Bipolar Depression Treatment Read More